Skip to main content
STRIDES PHARMA SCIENCE LIMITED logo

STRIDES PHARMA SCIENCE LIMITED — Investor Relations & Filings

Ticker · STAR ISIN · INE939A01011 LEI · 335800WHFYXUCHR9DD10 BSE.NS Manufacturing
Open in API
Filings indexed 1,189 across all filing types
Latest filing 2025-06-24 Regulatory Filings
Country IN India
Listing BSE.NS STAR

About STRIDES PHARMA SCIENCE LIMITED

https://www.strides.com

Strides Pharma Science Limited is a global pharmaceutical organization focused on the development and manufacture of IP-led niche finished dosage formulations. The company’s product portfolio encompasses a wide range of therapeutic areas, specializing in complex oral solids, softgel capsules, topicals, and liquids. It maintains a significant presence in highly regulated markets, including the United States, Europe, and Australia, while also serving institutional and emerging markets. The company operates multiple manufacturing facilities globally, many of which are approved by major international regulatory agencies such as the USFDA. Strides emphasizes research and development to drive innovation in specialized delivery systems and difficult-to-manufacture products, positioning itself as a key player in the global generic pharmaceutical landscape.

Recent filings

Filing Released Lang Actions
General Updates
Regulatory Filings
2025-06-24 English
Sale or disposal
Capital/Financing Update Classification · 95% confidence The document is a formal notification addressed to stock exchanges regarding the divestment of a dormant step-down wholly owned subsidiary of the company. It includes details such as the share transfer agreement date, consideration amount, buyer details, and compliance with SEBI Listing Regulations, specifically Regulation 30. The content is a disclosure announcement about a corporate action (divestment) rather than a financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial analysis but rather regulatory disclosure information about a transaction. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes, including divestments and share transfers.
2025-06-16 English
Retirement
Board/Management Information Classification · 95% confidence The document is a formal disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, announcing the superannuation (retirement) of a senior management personnel, Mr. Ramesh RJ, Senior Vice President – Treasury. It includes details about the cessation of employment and expresses appreciation for his service. There are no financial statements, earnings data, or report attachments. The content focuses on a change in senior management personnel, which fits the category of Board/Management Information (MANG). The document length is short and does not contain any financial or audit data, so it is not an Annual Report or Interim Report. Therefore, the correct classification is MANG with high confidence.
2025-05-30 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings conference call for the quarter and financial year ended March 31, 2025. It includes management commentary on financial results, operational performance, guidance, and Q&A with analysts. The text explicitly states it is a transcript of the earnings call, and it contains detailed financial metrics and management discussion. Therefore, this document fits the definition of a Call Transcript (CT).
2025-05-27 English
Updates
Major Shareholding Notification Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the submission of an application for promoter reclassification under Regulation 31A of SEBI Listing Regulations. It informs about the reclassification of certain entities from 'Promoter/Promoter Group' to 'Public' category. The document is an announcement of a regulatory action related to shareholding categories, not a full report or financial statement. It is short (1662 characters) and serves as an official notification to the exchanges. This fits the category of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels or promoter status.
2025-05-26 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) dated May 23, 2025, from Strides Pharma Science Limited. It references Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and encloses copies of newspaper advertisements published on the same date. These advertisements provide extracts of the Audited Financial Results for the quarter and financial year ended March 31, 2025. The document states that these extracts are also available on the company's website. The document itself is a notification about the publication of financial results in newspapers, not the full financial report or detailed financial statements. The length is 3990 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, according to the MENU VS MEAL RULE, this document is an announcement of the publication of audited financial results, not the full Annual Report or Earnings Release. The best fitting category is Regulatory Filings (RNS) as it is a regulatory announcement about the publication of financial results extracts in newspapers and on the website, but does not contain the full financial data or detailed report itself.
2025-05-23 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.